Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Bifidobacterium animalis subsp. lactis BB-12 and Improved Intestinal Barrier Function

Research synthesisLow evidenceModerate effect4 studies · 4 beneficial · 0 neutral · 0 harmful

Across 4 studies, all reported beneficial effects on intestinal barrier function, with predominantly moderate effect sizes. No studies reported statistically significant findings, and no specific dose or form was consistently studied. The evidence is drawn from systematic reviews, in vitro, and animal models, with limited clinical data.

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 4 studies) — conclusions should be considered preliminary. Many of the included studies did not reach statistical significance — effect may be smaller than the predominant direction suggests. Most studies were systematic reviews or in vitro/animal models, with limited direct human clinical data.

Generated Jul 11, 2026
4 of 4 papers
Back to top